DCH AURIGA SINGAPORE

**4.1 Therapeutic indications** Prevention of thromboembolic disease in patients (at high risk of developing VTE) undergoing total knee arthroplasty.

<p><strong>V. Indications</strong></p> <p>Trinomia is indicated for the secondary prevention of cardiovascular events as substitution therapy in adult patients adequately controlled with the monocomponents given concomitantly at equivalent therapeutical doses.</p>

**V. Indications** Trinomia is indicated for the secondary prevention of cardiovascular events as substitution therapy in adult patients adequately controlled with the monocomponents given concomitantly at equivalent therapeutical doses.

<p><strong>V. Indications</strong></p> <p>Trinomia is indicated for the secondary prevention of cardiovascular events as substitution therapy in adult patients adequately controlled with the monocomponents given concomitantly at equivalent therapeutical doses.</p>

<p><strong>4.1 Therapeutic indications</strong><br> For the dissolution of cholesterol gallstones in the gall bladder. The gallstones must not show as shadows on X-ray images and should not exceed 15 mm in diameter. Gall bladder must be functioning, despite the gallstones.<br> For the symptomatic treatment of primary biliary cirrhosis (PBC), in patients without decompensated hepatic cirrhosis.</p>

**4.1 Therapeutic indications** ELIGARD is indicated for the palliative treatment of hormone-dependent advanced prostate cancer.